Guardian Pharmacy Services, Inc. (GRDN) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Guardian Pharmacy Services, Inc. (GRDN) stock forecast summary
On Oct. 14, 2026, GRDN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for GRDN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, GRDN included.
Follow GRDN freeGRDN price chart and AI forecast
How GRDN ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Guardian Pharmacy Services, Inc. (GRDN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Retail-Drug Stores and Proprietary Stores peers listed below that report each metric.
Profitability & Margins
| Metric | GRDN | Rank |
|---|---|---|
| ROE | 26.8% | – |
| ROA | 14.9% | – |
| ROIC | 29.5% | – |
| Gross Margin | 21.6% | – |
| Operating Margin | 5.8% | – |
| Net Margin | 4.5% | – |
| EBT Margin | 6.5% | – |
| Tax Rate | 30.6% | – |
Financial Health
| Metric | GRDN | Rank |
|---|---|---|
| Current Ratio | 1.65x | – |
| Quick Ratio | 1.33x | – |
| D/E Ratio | 0.76x | – |
| Financial Leverage | 1.81x | – |
| Interest Coverage | 33.9x | – |
| Working Capital | $101M | – |
Cash Flow
| Metric | GRDN | Rank |
|---|---|---|
| Operating Cash Flow | $99M | – |
Operational Efficiency
| Metric | GRDN | Rank |
|---|---|---|
| Asset Turnover | 3.30x | – |
| Receivables Turnover | 14.1x | – |
| Inventory Turnover | 22.7x | – |
| Fixed Assets Turnover | 25.9x | – |
| Days Sales Outstanding | 26 days | – |
| Days Inventory | 16 days | – |
| Payables Period | 34 days | – |
| Cash Conversion Cycle | 8 days | – |
Income Statement
| Metric | GRDN | Rank |
|---|---|---|
| Total Revenue | $1.46B | – |
| Operating Income | $85M | – |
| Net Income | $65M | – |
| SG&A Expense | $231M | – |
| Cost of Goods Sold | $1.15B | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $255M | 57.4% of assets |
| Cash & Short-term Investments | $90M | 20.2% of assets |
| Accounts Receivable | $104M | 23.4% of assets |
| Inventory | $50M | 11.4% of assets |
| Total Liabilities | $186M | 41.9% of assets |
| Short-term Debt | $46M | 10.3% of assets |
GRDN quarterly financials and insider trading
Guardian Pharmacy Services, Inc. (GRDN) industry peers
Companies classified under the same SEC industry code as Guardian Pharmacy Services, Inc. (Retail-Drug Stores and Proprietary Stores): 5 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere GRDN sits on the market map
Guardian Pharmacy Services, Inc. (GRDN) stock news
Loading...
Guardian Pharmacy Services, Inc. (GRDN) stock forecast FAQ
What is the Guardian Pharmacy Services, Inc. (GRDN) stock forecast?
On Oct. 14, 2026, GRDN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
How accurate are Guardian Pharmacy Services, Inc. stock predictions?
A per-ticker accuracy statistic for GRDN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Guardian Pharmacy Services, Inc. forecasts updated?
Guardian Pharmacy Services, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Guardian Pharmacy Services, Inc.'s industry peers?
5 issuers in our coverage, GRDN included, share the SEC industry code Retail-Drug Stores and Proprietary Stores. The largest are: Cvs Health Corp (CVS), Petmed Express Inc (PETS), Trees Corp (Colorado) (CANN), Ridgetech Inc. (RDGT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.